Healthcare Professionals

Patients & Caregivers

Contact Us

2600 Stemmons Freeway, Suite 176
Dallas, TX 75207-2107
Tel: (214) 905-5100
Fax: (214) 905-5101

mugard@accesspharma.com

 

 





MuGard News Alerts

Sign up to receive FREE e-mail alerts about MuGard:

Presentations

Outsmarting Oral Mucositis - Presentation Poster 04.2013

Latest MuGard News & Events

04.29.13

Rush University Medical Center Presents Positive MuGard Clinical Data at the Oncology Nursing Society 38th Annual Congress

03.20.13

ACCESS PHARMACEUTICALS TO HOST FOURTH QUARTER AND FISCAL YEAR INVESTOR CALL ON WEDNESDAY, APRIL 3RD AT 11:00AM ET

10.25.12

ACCESS PHARMACEUTICALS ANNOUNCES PRIVATE PLACEMENT FINANCING

08.23.12

Access Pharmaceuticals To Host Second Quarter Investor Call on Thursday, August 23, 2012

06.28.12

Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium

Access Pharmaceuticals

MuGard Safety Information:

  • MuGard is safe to swallow
  • There are no known interactions with other medications
  • Reported side effects have been rare and generally mild

For full prescribing information, please click here.